This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Synox Therapeutics UK Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Georgina Meneses-Lorente: Innovator in Cancer Treatment
Introduction
Georgina Meneses-Lorente is a prominent inventor based in Welwyn Garden City, GB. She has made significant contributions to the field of cancer treatment, particularly through her innovative research and development of therapeutic agents.
Latest Patents
Georgina holds 1 patent for her invention titled "Dosages of emactuzumab." This patent relates to a treatment regime that includes an antibody or antigen-binding fragment capable of binding specifically to the colony stimulating factor-1 receptor (CSF-1R). The invention is aimed at treating tenosynovial giant cell tumour (TGCT) in subjects, along with associated uses and methods.
Career Highlights
Georgina is currently associated with Synox Therapeutics UK Limited, where she continues to advance her research in therapeutic solutions. Her work is pivotal in developing treatments that can significantly improve patient outcomes in oncology.
Collaborations
Throughout her career, Georgina has collaborated with notable professionals in her field, including Michael Cannarile and Raymond Barlow. These collaborations have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Georgina Meneses-Lorente exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her contributions through patents and collaborations highlight her commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile